NovaSight launches two telehealth technologies
In an effort to improve telehealth platforms through remote diagnostics and digital treatments, NovaSight has launched two products focused on tracking vision in children, according to a press release.
The EyeSwift is a vision assessment tool that monitors patient’s eye movements and provides evaluation of vision impairments through 11 different exams. The device has a CE mark and is FDA-registered.
The CureSight specializes in lazy eye treatment. With the intention of replacing traditional eye patching therapy, the system treats patients through 3D image processing algorithms and monitors patient progress. Treatment protocol is automatically adjusted through artificial intelligence. A large multicenter randomized trial is set to be conducted in 2020.
“In times like these, when we face a pandemic outbreak, it is essential to find ways to keep the population away from hospitals and large clinics,” Ran Yam, CEO of NovaSight, said in the release. “We are proud to be able to provide novel solutions for remote diagnostics and digital treatment.”